| Dr Vaishali S Shah, MD | |
|
677 Church St Ne, Attn: Hospitalist Office, Wellstar Kennestone Hospital, Marietta, GA 30060-1101 | |
| (770) 793-7750 | |
| (770) 793-7755 |
| Full Name | Dr Vaishali S Shah |
|---|---|
| Gender | Female |
| Speciality | Hospitalist |
| Experience | 32 Years |
| Location | 677 Church St Ne, Marietta, Georgia |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013986769 | NPI | - | NPPES |
| 09200071 | Medicaid | MS |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208M00000X | Hospitalist | 72804 (Georgia) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Wellstar Kennestone Hospital | Marietta, GA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Wellstar Medical Group, Llc | 6709065402 | 1839 |
News Archive
Type 1 diabetes affects 30,000 individuals throughout Germany and is the most common metabolic disease in children and adolescents. To halt the ever-increasing incidence, the young investigator group "Immunological Tolerance in Type 1 Diabetes" at the Institute of Diabetes Research directed by Prof. Dr. Anette-Gabriele Ziegler is exploring new strategies to prevent the onset of the disease.
Compugen Ltd. announced today the development of its Protein Family Members Discovery Platform, designed for the discovery of novel protein members belonging to various known and clinically important protein families.
A recent paper by British and Dutch scientists, currently available on the bioRxiv* preprint server, shows that the neutralizing activity of monoclonal antibodies can be dramatically reduced by mutations of the SARS-CoV-2 spike glycoprotein – unlike polyclonal antibodies generated after natural infection that remain active regardless of any introduced amino acid changes.
The economic uncertainty and healthcare issues affecting millions of Americans have hit the nation's cardiologists as well, according to a new survey: they are seeing more "baby boomer" patients than ever as Americans get older and demand more care. But they are being reimbursed less for those services by Medicare and insurance firms, in what one cardiologist calls "a revenue roller coaster of uncertainty."
Aradigm Corporation today announced that it dosed the first patient in the U.S. as part of its ORBIT-1 (Once-daily Respiratory Bronchiectasis Inhalation Treatment) trial, an international, randomized, double-blind, placebo-controlled Phase 2b study designed to evaluate the Company's inhaled liposomal ciprofloxacin (ARD-3100) in patients with non-cystic fibrosis bronchiectasis (BE) under a U.S. IND. This orphan disease indication is a chronic, severe respiratory disease and there are currently no approved treatments for this disease in the U.S.
› Verified 6 days ago
| Entity Name | Wellstar Medical Group, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1558664003 PECOS PAC ID: 6709065402 Enrollment ID: O20110127000374 |
News Archive
Type 1 diabetes affects 30,000 individuals throughout Germany and is the most common metabolic disease in children and adolescents. To halt the ever-increasing incidence, the young investigator group "Immunological Tolerance in Type 1 Diabetes" at the Institute of Diabetes Research directed by Prof. Dr. Anette-Gabriele Ziegler is exploring new strategies to prevent the onset of the disease.
Compugen Ltd. announced today the development of its Protein Family Members Discovery Platform, designed for the discovery of novel protein members belonging to various known and clinically important protein families.
A recent paper by British and Dutch scientists, currently available on the bioRxiv* preprint server, shows that the neutralizing activity of monoclonal antibodies can be dramatically reduced by mutations of the SARS-CoV-2 spike glycoprotein – unlike polyclonal antibodies generated after natural infection that remain active regardless of any introduced amino acid changes.
The economic uncertainty and healthcare issues affecting millions of Americans have hit the nation's cardiologists as well, according to a new survey: they are seeing more "baby boomer" patients than ever as Americans get older and demand more care. But they are being reimbursed less for those services by Medicare and insurance firms, in what one cardiologist calls "a revenue roller coaster of uncertainty."
Aradigm Corporation today announced that it dosed the first patient in the U.S. as part of its ORBIT-1 (Once-daily Respiratory Bronchiectasis Inhalation Treatment) trial, an international, randomized, double-blind, placebo-controlled Phase 2b study designed to evaluate the Company's inhaled liposomal ciprofloxacin (ARD-3100) in patients with non-cystic fibrosis bronchiectasis (BE) under a U.S. IND. This orphan disease indication is a chronic, severe respiratory disease and there are currently no approved treatments for this disease in the U.S.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Vaishali S Shah, MD 677 Church St Ne, Attn: Hospitalist Office, Wellstar Kennestone Hospital, Marietta, GA 30060-1101 Ph: (770) 793-7750 | Dr Vaishali S Shah, MD 677 Church St Ne, Attn: Hospitalist Office, Wellstar Kennestone Hospital, Marietta, GA 30060-1101 Ph: (770) 793-7750 |
News Archive
Type 1 diabetes affects 30,000 individuals throughout Germany and is the most common metabolic disease in children and adolescents. To halt the ever-increasing incidence, the young investigator group "Immunological Tolerance in Type 1 Diabetes" at the Institute of Diabetes Research directed by Prof. Dr. Anette-Gabriele Ziegler is exploring new strategies to prevent the onset of the disease.
Compugen Ltd. announced today the development of its Protein Family Members Discovery Platform, designed for the discovery of novel protein members belonging to various known and clinically important protein families.
A recent paper by British and Dutch scientists, currently available on the bioRxiv* preprint server, shows that the neutralizing activity of monoclonal antibodies can be dramatically reduced by mutations of the SARS-CoV-2 spike glycoprotein – unlike polyclonal antibodies generated after natural infection that remain active regardless of any introduced amino acid changes.
The economic uncertainty and healthcare issues affecting millions of Americans have hit the nation's cardiologists as well, according to a new survey: they are seeing more "baby boomer" patients than ever as Americans get older and demand more care. But they are being reimbursed less for those services by Medicare and insurance firms, in what one cardiologist calls "a revenue roller coaster of uncertainty."
Aradigm Corporation today announced that it dosed the first patient in the U.S. as part of its ORBIT-1 (Once-daily Respiratory Bronchiectasis Inhalation Treatment) trial, an international, randomized, double-blind, placebo-controlled Phase 2b study designed to evaluate the Company's inhaled liposomal ciprofloxacin (ARD-3100) in patients with non-cystic fibrosis bronchiectasis (BE) under a U.S. IND. This orphan disease indication is a chronic, severe respiratory disease and there are currently no approved treatments for this disease in the U.S.
› Verified 6 days ago
Bristol Yates Savage, MD Hospitalist Medicare: Medicare Enrolled Practice Location: 677 Church St Ne # 111, Marietta, GA 30060 Phone: 770-793-7750 | |
Manogna Maddineni, M.D Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 677 Church St Ne # 111, Marietta, GA 30060 Phone: 770-793-7750 | |
Dr. Anila Jacob, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 677 Church Street, Wellstar Hospitalist Group-wellstar Kennestone Hospital, Marietta, GA 30060 Phone: 770-793-7750 | |
Zhaneta Dzmitryieva, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 677 Church St Ne, Marietta, GA 30060 Phone: 770-793-7750 Fax: 770-793-7755 | |
Christy Nelson, FNP Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 310 Kennestone Hospital Blvd, Marietta, GA 30060 Phone: 877-354-1821 | |
Kumiko Owada, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 677 Church St Ne, Marietta, GA 30060 Phone: 770-793-5000 |